Tumor glycolytic phenotyping can be accomplished with 18F-FDG PET. Tumor 18F-FDG
uptake correlates with tumor grade in several cancers. However, the role of 18F-FDG PET …

Introduction Soft-tissue sarcomas (STS) are rare types of tumors that have variable levels of
tumor differentiation. F-18 fluorodeoxyglucose positron emission tomography (FDG PET) …

The purpose of this study was to evaluate 18F-FDG PET studies of primary and recurrent
sarcomas for diagnosis and correlation with grading. Methods: The evaluation included 56 …

Background The use of 18 F-FDG Positron emission tomography/Computed tomography
(PET/CT) in the initial staging of many cancers is clearly established. Most soft tissue …

Purpose Preoperative identification of aggressiveness is important for the establishment of a
treatment strategy in patients with soft-tissue sarcoma (STS). We compared the predictive …

PET using 18F-FDG is increasingly used for the diagnosis and grading of tumors. Several
studies have been performed that evaluate the diagnostic and grading performance of 18F …

By allowing simultaneous measurements of tumor volume and metabolic activity, integrated
PET/CT opens up new approaches for assessing tumor response to therapy. The aim of this …

Objectives To investigate the relationship between volume-based PET parameters and
prognosis in patients with soft tissue sarcoma (STS). Methods We retrospectively reviewed …

Positron emission tomography (PET) can be used to measure tumor metabolism in
sarcomas by measuring the standard uptake value (SUV) of (F-18) fluorodeoxyglucose …

Measurements of tumor glucose use by 18F-FDG PET need to be standardized within and
across institutions. Various parameters are used for measuring changes in tumor glucose …